TP53 Mutation is an Independent Prognostic Marker for Poor Outcome in Both Node-negative and Node-positive Breast Cancer

By Overgaard Jens   Yilmaz Mette   Guldberg Per   Hansen Lise Lotte   Alsner Jan  

Acta Oncologica, Vol. 39, Iss. 3, 2000-10 ,pp. : 327-333

Informa Healthcare

Access to resources Recommend Favorite

Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer

By Lamond Nathan   Skedgel Chris   Rayson Daniel   Lethbridge Lynn   Younis Tallal  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1115-1123

Springer Publishing Company

Access to resources Recommend Favorite

Angiogenesis and Blood Vessel Invasion as Prognostic Indicators for Node-Negative Breast Cancer

By Kato T.  

Breast Cancer Research and Treatment, Vol. 65, Iss. 3, 2001-02 ,pp. : 203-215

Springer Publishing Company

Access to resources Recommend Favorite

The prognostic value of MARCKS-like 1 in lymph node-negative breast cancer

By Jonsdottir Kristin   Zhang Hui   Jhagroe Darshni   Skaland Ivar   Slewa Aida   Björkblom Benny   Coffey Eleanor   Gudlaugsson Einar   Smaaland Rune   Janssen Emiel   Baak Jan  

Breast Cancer Research and Treatment, Vol. 135, Iss. 2, 2012-09 ,pp. : 381-390

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic factors affecting the natural history of node-negative breast cancer

By Trudeau Maureen  

Breast Cancer Research and Treatment, Vol. 89, Iss. 1, 2005-01 ,pp. : 35-45

Springer Publishing Company

Access to resources Recommend Favorite